CareDx (CDNA) has had the highest return since March 30, 2026 by a mid-cap US stock, returning 420.3%.
| ASSET | % RETURN |
|---|---|
CareDx (CDNA) | 420.3% |
MaxLinear (MXL) | 290.9% |
Abcellera Biologics (ABCL) | 275.23% |
10X Genomics (TXG) | 256.79% |
AMC Entertainment (AMC) | 218.75% |
Netskope, Inc Class A Common Stock (NTSK) | 213.55% |
Hinge Health (HNGE) | 213.21% |
Penguin Solutions (PENG) | 209.84% |
Tenable (TENB) | 202.44% |
Porch (PRCH) | 196.68% |
GRAIL, LLC (GRAL) | 192.71% |
Maravai Lifesciences Holdings (MRVI) | 172.13% |
Oscar Health (OSCR) | 171.89% |
BlackBerry (BB) | 165.62% |
Kodiak Sciences (KOD) | 164.2% |
Gitlab (GTLB) | 163.85% |
Insight Enterprises (NSIT) | 162.44% |
Xencor (XNCR) | 160.21% |
Amplitude (AMPL) | 159.97% |
Qualys (QLYS) | 159.76% |
Clover Health Investments (CLOV) | 159.3% |
Pulse Biosciences (PLSE) | 153.59% |
Xometry (XMTR) | 149.53% |
Five9 (FIVN) | 149.07% |
Schrodinger (SDGR) | 143.41% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.